- Home
- TFPM vs NARI Comparison
TFPM vs NARI Comparison
Compare TFPM & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFPM
- NARI
- Stock Information
- Founded
- TFPM 2016
- NARI 2011
- Country
- TFPM Canada
- NARI United States
- Employees
- TFPM N/A
- NARI N/A
- Industry
- TFPM Precious Metals
- NARI Medical/Dental Instruments
- Sector
- TFPM Industrials
- NARI Health Care
- Exchange
- TFPM Nasdaq
- NARI Nasdaq
- Market Cap
- TFPM 3.3B
- NARI 3.3B
- IPO Year
- TFPM N/A
- NARI 2020
- Fundamental
- Price
- TFPM $15.39
- NARI $55.45
- Analyst Decision
- TFPM Strong Buy
- NARI Buy
- Analyst Count
- TFPM 4
- NARI 11
- Target Price
- TFPM $20.50
- NARI $62.33
- AVG Volume (30 Days)
- TFPM 321.6K
- NARI 1.2M
- Earning Date
- TFPM 01-01-0001
- NARI 10-28-2024
- Dividend Yield
- TFPM 1.45%
- NARI N/A
- EPS Growth
- TFPM N/A
- NARI N/A
- EPS
- TFPM N/A
- NARI N/A
- Revenue
- TFPM $246,517,000.00
- NARI $574,498,000.00
- Revenue This Year
- TFPM $33.62
- NARI $24.62
- Revenue Next Year
- TFPM $11.43
- NARI $18.21
- P/E Ratio
- TFPM N/A
- NARI N/A
- Revenue Growth
- TFPM 25.66
- NARI 22.41
- 52 Week Low
- TFPM $11.75
- NARI $36.73
- 52 Week High
- TFPM $18.88
- NARI $66.61
- Technical
- Relative Strength Index (RSI)
- TFPM 34.49
- NARI 58.83
- Support Level
- TFPM $15.81
- NARI $53.85
- Resistance Level
- TFPM $17.01
- NARI $58.00
- Average True Range (ATR)
- TFPM 0.40
- NARI 3.02
- MACD
- TFPM -0.12
- NARI -0.05
- Stochastic Oscillator
- TFPM 11.47
- NARI 63.75
About TFPM Triple Flag Precious Metals Corp.
Triple Flag Precious Metals Corp is a precious-metals-focused streaming and royalty company. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Honduras, Mexico, Mongolia, Peru, South Africa, and the United States.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.